An innovative concept in the analysis of specific immunotherapy (SIT) data has consistently better discriminatory power and could lead to change in the efficacy evaluation paradigm
Read More
Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines announces interim results for the six months ended 31 December 2009.
